HC Wainwright reaffirmed their buy rating on shares of Valneva (NASDAQ:VALN – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $17.00 price ...
The positive CHMP opinion is supported by positive six-month adolescent Phase 3 data which Valneva reported in May 2024 2. These data, collected through a study in Brazil funded by the Coalition ...
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...
The vaccine, manufactured by the biotechnology company Valneva, was the first vaccine approved by the US Food and Drug Administration to prevent disease caused by chikungunya virus. The approval ...
The COVID-19 virus spreads mainly through exposure to airborne droplets infected with the virus. While it's possible to be infected with COVID by coming in contact with a surface with the virus on ...
The announcement, posted to the CDC’s website, said the five, all aged 65 or older, were hospitalized for cardiac or neurological events after receiving Ixchiq, a vaccine made by Valneva ...
The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to supply COVID-19 vaccines that was terminated by the UK government this week.
an inactivated whole-virus COVID-19 vaccine. Receive News & Ratings for Valneva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...
By Danial Adkison Those dark days began almost five years ago. On March 11, 2020, the World Health Organization declared Covid-19 a pandemic, and four days later, U.S. states began to order ...
In a report released on February 18, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a price target of €8.10. The company’s shares ...